Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines - Wikidata - awgldk - TriplyDB

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines

http://www.wikidata.org/entity/Q36823959

about

Phage therapy against Enterococcus faecalis in dental root canals The Therapeutic Benefit of Bacterial Membrane Vesicles.Bacterial membrane vesicles: Biogenesis, immune regulation and pathogenesis.Polysaccharide Utilization Loci: Fueling Microbial Communities.The Secrets of Acinetobacter Secretion.Cell membrane-derived nanomaterials for biomedical applications.In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.Co-administration of the Campylobacter jejuni N-glycan based vaccine with probiotics improves vaccine performance in broiler chickens.Bacterial outer membrane vesicles: New insights and applications.Characterization of the pgf operon involved in the posttranslational modification of Streptococcus mutans surface proteins.Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.Potential targets for next generation anti-microbial glycoconjugate vaccines.Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives.Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants.

P2860

Q28071930-1FBF765C-6EBE-4552-9246-07A02A4F3090 Q33839021-8422347E-3FA5-493F-82E7-2427F36184CB Q38937829-8E060B35-D9CE-40C5-82F4-7BC7D7B8559E Q39110296-C16A5026-D5FC-452C-AF4D-A4E90DFB2EBC Q39143150-18928E0D-B702-4FF0-979E-192D1377B05E Q39178313-F5079832-EB78-4E39-B5EA-D75D43B24072 Q47216488-E5A3E81B-8E82-420B-AB07-B73B7023A9C7 Q48653028-BC640B24-BC2E-4B6A-BEDB-D2C9F36372B0 Q49496755-C6284945-8AFF-4100-A590-7E1F7E5D84BC Q52352251-1817D444-28BA-4BF7-9E75-E3A10671BB04 Q52725623-01A30D6B-2C78-4989-860E-0D3A9501838A Q53701548-BDD82BF3-E3D3-408B-8D2A-7DE0C1ED5453 Q55091449-D07B5818-0A31-4C09-BFF6-AAC5DDF97AC0 Q55380286-695E53AC-608B-4BCD-BC9A-6750C12A249F

P2860

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines

http://www.wikidata.org/entity/Q36823959

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines

@en

type

label

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines

@en

prefLabel

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines

@en

P1433

Q36823959-DB94B68C-D15B-47F3-BD2A-8E758C8818B9

P1476

Q36823959-BD1557DA-79FA-432D-8AC8-A87F4142F836

P2093

Q36823959-0958FD8F-9B31-42D0-9082-F54C12D671C5

Q36823959-51E36551-8ABE-447E-A386-872C9FF67F1C

Q36823959-6F2AC7D8-51EF-4E1E-93C1-06D68162FAB9

Q36823959-CF070D0F-C2A0-46AC-A6B4-9C48966F50F9

Q36823959-EACDE246-5A9B-45A5-B9E5-C8D57E8EC14A

Q36823959-EB8B5E7C-A397-4EDE-8213-34922188650A

P2860

Q36823959-03B975B5-3FD1-47B3-9F72-1F7D4B7F0BA0

Q36823959-03ECC356-E602-4B53-8ED3-67444F67FB55

Q36823959-065D28FD-E565-41F4-89B1-EFD584F6D383

Q36823959-073DD1C8-9BD0-4220-AD66-01831A69549E

Q36823959-086F03F9-5946-4650-99A9-81512644CEE0

Q36823959-087DAAA8-ADD6-4D7F-8013-4805A44E8351

Q36823959-13CBB971-475A-4015-A5AB-6B2C80342B83

Q36823959-1CC379FA-9374-481D-8E87-8F29AD1C7CE8

Q36823959-1FDF0A52-BE1B-49DA-B9DA-07A52DBFBC28

Q36823959-2D8C9873-78B5-4677-9C0A-72323A4DF7F7

P2888

Q36823959-2B79656A-304F-40C7-A5C2-9F58BEC3496D

P304

Q36823959-0D7BCE47-50C6-4C1C-942E-8D40D1C34492

P31

Q36823959-6E960031-7E99-4905-8C0F-821D47EFFB00

P356

Q36823959-45455DF0-5DEA-48ED-865D-DCDD1B8F03C0

P407

Q36823959-71B7B813-E1E5-49FC-9763-6E150B4D4E97

P478

Q36823959-301036C6-17ED-4F5E-95B0-3D7D4B438DAE

P50

Q36823959-51B73AD6-A729-4F94-B6FD-46D6ABC55F65

P577

Q36823959-D9FFE7BB-A2FD-4139-99EE-32306C6C73AF

P698

Q36823959-B5B6EFA1-BD5D-435A-A49A-344F11E71D4F

P932

Q36823959-DDD2E31B-2320-4565-A573-844A2EC4EE3D

P356

P1433

Scientific Reports

P1476

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines

@en

P2093

Christine M Szymanski

http://www.w3.org/2001/XMLSchema#string

Ezequiel Valguarnera

http://www.w3.org/2001/XMLSchema#string

Guillaume Goyette-Desjardins

http://www.w3.org/2001/XMLSchema#string

Harald Nothaft

http://www.w3.org/2001/XMLSchema#string

Mario F Feldman

http://www.w3.org/2001/XMLSchema#string

Nancy L Price

http://www.w3.org/2001/XMLSchema#string

P2860

Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles

Bacterial outer membrane vesicles and vaccine applications

Lipopolysaccharide endotoxins

Development of Burkholderia mallei and pseudomallei vaccines

Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli.

Virulence and immunomodulatory roles of bacterial outer membrane vesicles.

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.

Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.

P2888

P304

24931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP24931

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27103188

http://www.w3.org/2001/XMLSchema#string

P932

4840304

http://www.w3.org/2001/XMLSchema#string